Investments

Biofarma is the global leading player in the development, manufacturing, and packaging of health supplements, medical devices and cosmetics for large Pharma and CPG clients.
Biofarma offers its clients an integrated offer, from market intelligence, R&D and regulatory support, to manufacturing and packaging of finished dosage form products. Biofarma differentiates itself for its capacity to develop and proactively offer its clients innovative solutions by combining differentiated manufacturing technologies, delivery systems, and formulation capabilities. In addition, Biofarma has a strong expertise in probiotics and has an innovative portfolio of Medical Devices, supported by clinical studies and for which it owns dossiers.
As a result of this differentiated positioning, Biofarma is the partner-of-choice of large Pharma and Consumer Health (‘CHCs’) clients for co-development projects requiring strong innovation capabilities, international regulatory capabilities, and manufacturing quality reliability.

Founded in 1954 and based in Eustis, Florida, Vibrant Ingredients operates a multifunctional production facility and is involved in manufacturing of food protection ingredients, vegetable juice concentrates and derivatives used in a multitude of food applications from savory to beverages, sports nutrition and meats, and are marketed globally. The company has offered a portfolio of healthy, natural, clean label solutions for over 60 years.

Jakala is the leading European player in AI-powered, data-driven performance. The company delivers measurable business impact across revenue, engagement, productivity, and efficiency by seamlessly connecting strategy, technology, and data activation across the full customer lifecycle. Built on over 20 years of proprietary, privacy-safe customer intelligence, Jakala transforms organisational data and decision logic into scalable, outcome-driven solutions. With deep expertise across Financial Services, Retail, Luxury, Pharma, and other key sectors, and a strong entrepreneurial culture powering an active M&A strategy, Jakala is building the European category leader at the intersection of data, AI and customer performance.

GBA Group is a leading independent provider of highest-quality bio-analytical laboratory services for food, sustainability & environment, medical device, and pharmaceutical testing. The group focuses on tailor-made solutions to meet its clients’ needs, backed by its strong scientific expertise, very comprehensive service portfolio as well as continuous dialogue with its customers. Headquartered in Hamburg, GBA employs well over 2,500 employees and operates more than 65 labs across central Europe, the US and Asia.

Founded in 2009, AD Education is a leading European private higher education platform, notably in the field of Creative Arts, Business and Engineering, teaching to c.42,000 students in 20 schools on 72 campuses and online in 9 European countries (notably in France, Italy, Spain, Germany and more recently the UK). AD Education covers 7 main sub-segments: Engineering, Business, Design & Graphic Arts, Digital & Communication, Culture & Luxury, Audiovisual and Other (IT, Tech). Over the past 10 years, the Group has established itself as the French leader on its core educational fields, following continued organic growth as well as successful build-ups, and as a sizeable European platform following several acquisitions in Europe (mainly Italy, Spain, Germany and the UK).

Founded in 2010, Inovie has undergone significant external growth to become the leading independent medical diagnostic provider in France and a key player across Southern and Central France specifically. With a strong local footprint of 23 multi-site laboratories spread over seven key regions (Occitanie, Provence-Alpes-Côte-d’Azur, Nouvelle Aquitaine, Auvergne Rhône Alpes, Centre Val de Loire, Pays de la Loire and Bretagne), Inovie’s biologists and more than 6,000 employees deliver high-standard clinical pathology testing to more than 100,000 patients daily. Inovie has also played a leading role in innovation, notably through their work in four areas of specialty: fertility (Inovie Fertilité), genomics (Imagenome), anatomopathology (Inopath) and veterinary services (Inovie Vet).